EcoDrugPlus

Sphingosine Kinase 2

Ensembl ID : ENSPNYG00000002473
Gene Symbol: SPHK2
2 Cross references
200 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSPNYG00000003887
Gene Symbol: SYK
3 Cross references
200 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSPNYG00000002693
Gene Symbol: LOC102214279
3 Cross references
210 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSPNYG00000014573
Gene Symbol: SRD5A2
3 Cross references
191 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSPNYG00000007771
Gene Symbol: SOAT1
3 Cross references
210 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSPNYG00000006656
Gene Symbol: TACR1
3 Cross references
195 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSPNYG00000016035
Gene Symbol: TACR2
3 Cross references
199 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSPNYG00000018145
Gene Symbol: TACR3
3 Cross references
208 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSPNYG00000000769
Gene Symbol: TERT
3 Cross references
189 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSPNYG00000019643
Gene Symbol: TBXA2R
3 Cross references
192 Possible Orthologues:

Thromboxane-A Synthase-Like

Ensembl ID : ENSPNYG00000020968
Gene Symbol: LOC102203832
3 Cross references
209 Possible Orthologues:

Thromboxane-A Synthase-Like

Ensembl ID : ENSPNYG00000021010
Gene Symbol: LOC102204114
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).